PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 26, 2026Drug Resistance Updates2 citationsOpen Access

Recent Advances in Near-Infrared Fluorescent Ligands as a Novel Frontier in Combating Antibiotic-Resistant Bacteria

View Full Paper
WZWen-De ZhengYZYao-Xun ZengZCZe-Xin Chen

Key Points

  • To summarize recent developments in near-infrared fluorescent ligands for treating multi-drug-resistant bacterial infections.
  • Review of recent literature on near-infrared fluorescent ligands
  • Analysis of molecular classes including dyes and analogues
  • Discussion of mechanisms and photophysical properties of compounds
  • Near-infrared phototherapy shows potential in targeting bacterial proteins and nucleic acids.
  • Reactive oxygen species are produced to damage multi-drug-resistant bacteria.
  • Various organic compounds, like cyanine dyes and tetraphenylethene, demonstrate effective antibacterial properties.

Abstract

The emergence and rapid spread of multi-drug-resistant (MDR) bacteria pose a serious and escalating threat to global public health, undermining the effectiveness of conventional antibiotics and demanding urgent development of alternative therapeutic strategies. Among these, phototherapy mediated by organic fluorescent ligands has gained increasing attention as a promising antimicrobial approach due to its spatiotemporal precision, minimal invasiveness, and reduced risk of resistance development. In phototherapeutic antimicrobial applications, near-infrared (NIR) photosensitizers are activated by light to produce reactive oxygen species (ROS) or localized heat, leading to targeted damage of bacterial membranes, proteins, and nucleic acids. This review provides a focused summary of recent advances over the past decade in the design and application of NIR organic fluorescent ligands for antibacterial phototherapy. We discuss key molecular classes which include cyclic tetrapyrroles, phenothiazinium salts, cyanine dyes, BODIPYs and aza-BODIPYs, tetraphenylethene, and triphenylamine analogues, highlighting their structural features, photophysical properties, and mechanisms of action. By consolidating these developments, our aim is to offer a comprehensive and accessible resource that supports future innovation and encourages interdisciplinary collaboration. This review contributes meaningfully to the ongoing scientific and clinical discourse on antimicrobial resistance, highlighting novel phototherapy-based solutions with potential for real-world impact.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zheng et al. (2026) studied this question.

synapsesocial.com/papers/699f95841bc9fecf3dab352dhttps://doi.org/10.1016/j.drup.2026.101382
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1pH‐Responsive PEG–Doxorubicin‐Encapsulated Aza‐BODIPY Nanotheranostic Agent for Imaging‐Guided Synergistic Cancer Therapy2018 · 125 citations
  2. 2A Review on Advanced Nanomaterials for Antibacterial Applications2023 · 6 citations
  3. 3The Microbiologist’s Guide to Membrane Potential Dynamics2020 · 354 citations
  4. 4Hyaluronic Acid-Templated Ag Nanoparticles/Graphene Oxide Composites for Synergistic Therapy of Bacteria Infection2017 · 131 citations
  5. 5The Antimicrobial Resistance Crisis: Causes, Consequences, and Management2014 · 1,005 citations